Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ENvue Medical, Inc. FEED

Set alert

Price alert · FEED

All alert types
0.21 USD -0.04 -15.14%

As of Nov 2, 3:20 PM ET

Bid
0.57 × 4,998
Ask
0.59 × 5,000
0.203 Day range 0.30
0.121 52-week range 73.08
YTD
-99.25%
1 year
-99.67%
Open
0.26
Prev close
0.2444
Mkt cap
191.58K
Vol
24.34K
Avg vol
84.88K
EPS
-381.94
P/E
0.00
Div yield
0.00%
More statistics
Low
0.203
High
0.30

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Sep 1, 2026Split: 1 for 12
Signals (17)
NameDateAgo
RSI: OversoldOct 23, 20261 week ago
RSI: OversoldOct 16, 20262 weeks ago
MACD: Buy SignalOct 2, 20261 month ago
RSI: OversoldSep 15, 20261 month ago
MACD: Sell SignalAug 31, 20262 months ago
RSI: OversoldJul 13, 20263 months ago
MACD: Buy SignalJul 7, 20263 months ago
RSI: OversoldJul 2, 20264 months ago
MACD: Sell SignalJun 24, 20264 months ago
RSI: OversoldJun 23, 20264 months ago
RSI: OversoldJun 18, 20264 months ago
RSI: OversoldJun 8, 20264 months ago
RSI: OversoldJun 3, 20265 months ago
MACD: Buy SignalMay 22, 20265 months ago
MACD: Sell SignalMay 19, 20265 months ago
RSI: OversoldMay 19, 20265 months ago
MACD: Buy SignalMay 6, 20266 months ago

Financial health

Altman Z-Score

-5.81 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.1×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.0×FY 2025: -0.1×
FY 2016 5y median -0.0× FY 2025
P/S 0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.8×
FY 2016 5y median 0.0× FY 2025
P/B 0.1×
FY 2016: -0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.0× FY 2025
P/FCF -0.2×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -0.0×FY 2022: -0.0×FY 2023: -0.0×FY 2024: -0.1×FY 2025: -0.2×
FY 2016 5y median -0.0× FY 2025
EV/EBITDA 0.1×
FY 2016: 0.0×FY 2017: 1.2×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 1.8×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.9×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.5× FY 2025
EV/Sales -0.4×
FY 2016: -0.4×FY 2017: -18.2×FY 2018: -2.8×FY 2019: -2.5×FY 2020: -12.0×FY 2021: -4.5×FY 2022: -3.4×FY 2023: -1.4×FY 2024: -0.2×FY 2025: -0.4×
FY 2016 5y median -1.4× FY 2025
FCF Yield -475.6%
FY 2016: -15827.1%FY 2017: -20622.6%FY 2018: -25909.7%FY 2019: -26172.8%FY 2020: -15458.4%FY 2021: -8147.7%FY 2022: -11632.9%FY 2023: -4828.0%FY 2024: -1990.1%FY 2025: -475.6%
FY 2016 5y median -4828.0% FY 2025

Profitability

Gross Margin 6.0%
FY 2016: 61.6%FY 2017: 63.2%FY 2018: 50.3%FY 2019: 53.0%FY 2020: 34.3%FY 2021: 45.4%FY 2022: 22.2%FY 2023: 67.3%FY 2024: 59.0%FY 2025: 6.0%
FY 2016 5y median 45.4% FY 2025
Operating Margin -459.7%
FY 2016: -1011.4%FY 2017: -1293.3%FY 2018: -1353.1%FY 2019: -971.9%FY 2020: -757.5%FY 2021: -335.3%FY 2022: -666.5%FY 2023: -150.5%FY 2024: -140.0%FY 2025: -459.7%
FY 2016 5y median -335.3% FY 2025
Net Margin -712.3%
FY 2016: -1236.2%FY 2017: -2429.3%FY 2018: -1306.3%FY 2019: -1093.2%FY 2020: -694.2%FY 2021: -842.6%FY 2022: -724.5%FY 2023: -162.5%FY 2024: -144.8%FY 2025: -712.3%
FY 2016 5y median -712.3% FY 2025
ROE -54.3%
FY 2016: 113.3%FY 2017: -159.8%FY 2018: -897.2%FY 2019: -429.8%FY 2020: -180.7%FY 2021: -226.2%FY 2022: -168.5%FY 2023: -93.1%FY 2024: -590.9%FY 2025: -54.3%
FY 2016 5y median -168.5% FY 2025
ROIC -32.4%
FY 2016: 3262.0%FY 2017: -76.0%FY 2018: -444.2%FY 2019: -315.7%FY 2020: -88.4%FY 2021: -84.0%FY 2022: -137.5%FY 2023: -81.3%FY 2024: -373.5%FY 2025: -32.4%
FY 2016 5y median -84.0% FY 2025
ROA -44.2%
FY 2016: -573.1%FY 2017: -119.3%FY 2018: -262.9%FY 2019: -284.6%FY 2020: -52.6%FY 2021: -165.6%FY 2022: -92.7%FY 2023: -55.6%FY 2024: -102.1%FY 2025: -44.2%
FY 2016 5y median -92.7% FY 2025

Growth (YoY)

Revenue -0.2%
FY 2016: 55.8%FY 2017: 4.4%FY 2018: 33.1%FY 2019: 66.7%FY 2020: 17.5%FY 2021: 172.1%FY 2022: -55.6%FY 2023: 203.6%FY 2024: 12.0%FY 2025: -0.2%
FY 2016 FY 2025
Operating Income -227.6%
FY 2016: -62.6%FY 2017: -33.5%FY 2018: -39.2%FY 2019: -19.7%FY 2020: 8.4%FY 2021: -20.4%FY 2022: 11.8%FY 2023: 31.4%FY 2024: -4.2%FY 2025: -227.6%
FY 2016 FY 2025
EPS (diluted) 85.8%
FY 2016: 57.5%FY 2017: -88.7%FY 2018: 44.9%FY 2019: -29.6%FY 2020: 49.7%FY 2021: -35.1%FY 2022: 66.2%FY 2023: 44.7%FY 2024: 41.1%FY 2025: 85.8%
FY 2016 FY 2025
Free Cash Flow -274.4%
FY 2016: -4.1%FY 2017: -41.6%FY 2018: -63.1%FY 2019: -8.9%FY 2020: 12.4%FY 2021: -28.8%FY 2022: -61.1%FY 2023: 48.8%FY 2024: 30.1%FY 2025: -274.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 0.4×FY 2017: 5.7×FY 2018: 1.9×FY 2019: 4.5×FY 2020: 2.7×FY 2021: 4.4×FY 2022: 2.4×FY 2023: 2.6×FY 2024: 1.2×FY 2025: 1.1×
FY 2016 5y median 2.4× FY 2025
Quick Ratio 0.7×
FY 2016: 0.3×FY 2017: 5.6×FY 2018: 1.7×FY 2019: 4.2×FY 2020: 2.7×FY 2021: 4.3×FY 2022: 1.5×FY 2023: 1.5×FY 2024: 0.4×FY 2025: 0.7×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.2×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 0.0×FY 2017: 1.2×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 1.8×FY 2021: 0.5×FY 2022: 0.5×FY 2023: 0.9×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -40.7×
FY 2016: -154×FY 2017: -2.4×FY 2018: 0.0×FY 2019: -83.1×FY 2020: -32.1×FY 2021: 0.0×FY 2022: -14.4×FY 2023: -14.0×FY 2024: -26.5×FY 2025: -40.7×
FY 2016 5y median -14.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31